SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003002
Filing Date
2022-03-07
Accepted
2022-03-07 16:14:23
Documents
19
Period of Report
2022-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-20220307.htm   iXBRL 8-K 75567
2 EX-5.1 bdsx-ex5_1.htm EX-5.1 24987
3 EX-10.1 bdsx-ex10_1.htm EX-10.1 474019
4 EX-10.2 bdsx-ex10_2.htm EX-10.2 188908
5 EX-99.1 bdsx-ex99_1.htm EX-99.1 16324
6 GRAPHIC img189760734_0.jpg GRAPHIC 2870
7 GRAPHIC img203172065_0.gif GRAPHIC 7851
8 GRAPHIC img203172065_1.jpg GRAPHIC 16426
  Complete submission text file 0000950170-22-003002.txt   1048582

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsx-20220307_lab.xml EX-101.LAB 18612
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsx-20220307.xsd EX-101.SCH 2488
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsx-20220307_pre.xml EX-101.PRE 11596
13 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20220307_htm.xml XML 4886
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 22718153
SIC: 8071 Services-Medical Laboratories